
|Videos|December 28, 2022
2022 SUO Annual Meeting recap: Updates in intermediate-risk non–muscle-invasive bladder cancer
Author(s)Urology Times staff
Laura Bukavina, MD, MPH, summarizes a presentation from the 2022 Society of Urologic Oncology Annual Meeting from Sarah P. Psutka, MD, MS.
Advertisement
In this video, Laura Bukavina, MD, MPH, summarizes the 2022 Society of Urologic Oncology Annual Meeting presentation, “Intermediate-risk NMIBC: Updates on Trials & New Horizons.” Bukavina is a urologic oncology fellow at Fox Chase Cancer Center in Philadelphia, Pennsylvania.
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA provides guidance on development pathway for testosterone therapy for women
2
Treatment Selection in Advanced Prostate Cancer
3
Annual ACS NCDB report details national trends in prostate cancer care
4
Advice for the Next Generation of Urologists in mCSPC Management
5






